Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex.
View Top Employees from Evofem BiosciencesWebsite | http://www.evofem.com |
Ticker | EVFM |
Revenue | $11.4 million |
Funding | $150.6 million |
Employees | 91 (91 on RocketReach) |
Founded | 2015 |
Address | 12636 High Bluff Dr. Suite 400, San Diego, California 92130, US |
Phone | (858) 550-1900 |
Fax | (858) 750-1013 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Lifestyle, Community and Lifestyle, Medical, Women's |
Web Rank | 21 Million |
Keywords | Evofem Biosciences |
Competitors | CONRAD, Dynavax Technologies, KBP Biosciences, Otonomy, Inc, Y-mAbs Therapeutics, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Evofem Biosciences employee's phone or email?
The Evofem Biosciences annual revenue was $11.4 million in 2024.
Katherine Mercier is the Vice President Technical Operations of Evofem Biosciences.
91 people are employed at Evofem Biosciences.
Evofem Biosciences is based in San Diego, California.
The NAICS codes for Evofem Biosciences are [32, 3254, 32541, 325].
The SIC codes for Evofem Biosciences are [28, 283].